CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: Possible involvement of regulatory T cells in disease progression

Cancer

Volumn 98, Issue 5, 2003, Pages 1089-1099

  Sasada, Tetsuro ^a   Kimura, Motohide ^a   Yoshida, Yuka ^a   Kanai, Michiyuki ^a   Takabayashi, Arimichi ^a  

^a Kitano Hospital   (Japan)

Author keywords

CD4+CD25+ T cells; Cytokine; Gastrointestinal malignancies; Immunosuppression; Regulatory T cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ADULT; ADVANCED CANCER; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES; CANCER GROWTH; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIGESTIVE SYSTEM CANCER; FEMALE; HUMAN; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; STOMACH CARCINOMA; T LYMPHOCYTE;

ADULT; AGED; ANTIGENS, CD4; CD4 LYMPHOCYTE COUNT; CYTOKINES; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNE SYSTEM; IMMUNE TOLERANCE; MALE; MIDDLE AGED; PHENOTYPE; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES;

EID: 0041386189     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11618     Document Type: Article

References (36)

1. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell. 2000;101:455-458.
2. + suppressor T cells. J Exp Med. 2001;193:F41-F46.
3. Weiner HL. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev. 2001;182:207-214.
4. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997;389:737-742.
5. Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res. 1999;59:3128-3133.
6. + T cells: a common basis between tumor immunity and autoimmunity. J Immunol. 1999;163:5211-5218.
7. + T-cell-dependent immune defense of B16 melanoma. Cancer Res. 2001;61:8643-8646.
8. + regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med. 2001;194:823-832.
9. + regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes. J Immunother. 2002;25:207-217.
10. + T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol. 2001;31:1122-1131.
11. + thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol. 2001;31:1247-1254.
12. + T cells with regulatory properties isolated from peripheral blood. J Exp Med. 2001;193:1285-1294.
13. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med. 2001;193:1295-1302.
14. + T cells with regulatory properties from human blood. J Exp Med. 2001;193:1303-1310.
15. high regulatory cells in human peripheral blood. J Immunol. 2001;167:1245-1253.
16. + cells: a naturally occurring population of regulatory T cells. Blood. 2001;98:2736-2744.
17. Sobin LH, Wittekind C, editors. TNM classification of malignant tumors (5th edition). New York: John Wiley & Sons, 1997.
18. Rosenberg SA. Progress in human tumour immunology and immunotherapy. Nature. 2001;411:380-384.
19. + T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res. 2001;61:4766-4772.
20. Woo EY, Yeh H, Chu CS, et al. Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol. 2002;168:4272-4276.
21. Wolf AM, Wolf D, Steurer M, Gastl G, Gunsilius E, Grubeck-Loebenstein B. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res. 2003;9:606-612.
22. Papiernik M, do Carmo Leite-de-Moraes M, Pontoux C, et al. T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10-producing T cell population with infectious capacity. J Immunol. 1997;158:4642-4653.
23. Banz A, Pontoux C, Papiernik M. Modulation of Fas-dependent apoptosis: a dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells. J Immunol. 2002;169:750-757.
24. + T cell response to repetitive stimulation with antigen-presenting cells in vitro: implications in designing antigen-presenting cell-based tumor vaccines. J Immunol. 1999;162:5576-5583.
25. Jonuleit H, Schmitt E, Steinbrink K, Enk AH. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 2001;22:394-400.
26. Bell D, Chomarat P, Broyles D, et al. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med. 1999;190:1417-1426.
27. Almand B, Clark JI, Nikitina E, et al. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol. 2001;166:678-689.
28. + T-regulatory cells and systemic collapse of antitumour immunity. Immunology. 2001;103:449-457.
29. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J Immunol. 2001;166:3008-3018.
30. Ge Q, Palliser D, Eisen HN, Chen J. Homeostatic T cell proliferation in a T cell-dendritic cell coculture system. Proc Natl Acad Sci U S A. 2002;99:2983-2988.
31. Mocellin S, Wang E, Marincola FM. Cytokines and immune response in the tumor microenvironment. J Immunother. 2001;24:392-407.
32. + T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression. Cancer Immunol Immunother. 1996;42:1-8.
33. Tabata T, Hazama S, Yoshino S, Oka M. Th2 subset dominance among peripheral blood T lymphocytes in patients with digestive cancers. Am J Surg. 1999;177:203-208.
34. De Vita F, Orditura M, Galizia G, et al. Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies. Cancer. 1999;86:1936-1943.
35. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057-1061.
36. Dudley ME, Wunderlich JR, Robbins PF, et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science. 2002;298:850-854.